VEGFA and hepatocellular carcinoma: Analysis of individual cases confirmed frequent VEGFA-189 repression in HCC (≥2-fold downregulation was detected in 56% cases) while VEGFA-165 and VEGFA-121 variants displayed significant changes in smaller fraction of cases (22% and 32%, respectively) (Figs. 2C–2E).